Cargando…

Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy

INTRODUCTION: Image-based early detection for diabetic retinopathy (DR) needs value addition due to lack of well-defined disease-specific quantitative imaging biomarkers (QIBs) for neuroretinal degeneration and spectropathological information at the systemic level. Retinal neurodegeneration is an ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Guha Mazumder, Arpan, Chatterjee, Swarnadip, Chatterjee, Saunak, Gonzalez, Juan Jose, Bag, Swarnendu, Ghosh, Sambuddha, Mukherjee, Anirban, Chatterjee, Jyotirmoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703157/
https://www.ncbi.nlm.nih.gov/pubmed/29200821
http://dx.doi.org/10.2147/OPTH.S140110
_version_ 1783281649235001344
author Guha Mazumder, Arpan
Chatterjee, Swarnadip
Chatterjee, Saunak
Gonzalez, Juan Jose
Bag, Swarnendu
Ghosh, Sambuddha
Mukherjee, Anirban
Chatterjee, Jyotirmoy
author_facet Guha Mazumder, Arpan
Chatterjee, Swarnadip
Chatterjee, Saunak
Gonzalez, Juan Jose
Bag, Swarnendu
Ghosh, Sambuddha
Mukherjee, Anirban
Chatterjee, Jyotirmoy
author_sort Guha Mazumder, Arpan
collection PubMed
description INTRODUCTION: Image-based early detection for diabetic retinopathy (DR) needs value addition due to lack of well-defined disease-specific quantitative imaging biomarkers (QIBs) for neuroretinal degeneration and spectropathological information at the systemic level. Retinal neurodegeneration is an early event in the pathogenesis of DR. Therefore, development of an integrated assessment method for detecting neuroretinal degeneration using spectropathology and QIBs is necessary for the early diagnosis of DR. METHODS: The present work explored the efficacy of intensity and textural features extracted from optical coherence tomography (OCT) images after selecting a specific subset of features for the precise classification of retinal layers using variants of support vector machine (SVM). Fourier transform infrared (FTIR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy were also performed to confirm the spectropathological attributes of serum for further value addition to the OCT, fundoscopy, and fluorescein angiography (FA) findings. The serum metabolomic findings were also incorporated for characterizing retinal layer thickness alterations and vascular asymmetries. RESULTS: Results suggested that OCT features could differentiate the retinal lesions indicating retinal neurodegeneration with high sensitivity and specificity. OCT, fundoscopy, and FA provided geometrical as well as optical features. NMR revealed elevated levels of ribitol, glycerophosphocholine, and uridine diphosphate N-acetyl glucosamine, while the FTIR of serum samples confirmed the higher expressions of lipids and β-sheet-containing proteins responsible for neoangiogenesis, vascular fragility, vascular asymmetry, and subsequent neuroretinal degeneration in DR. CONCLUSION: Our data indicated that disease-specific spectropathological alterations could be the major phenomena behind the vascular attenuations observed through fundoscopy and FA, as well as the variations in the intensity and textural features observed in OCT images. Finally, we propose a model that uses spectropathology corroborated with specific QIBs for detecting neuroretinal degeneration in early diagnosis of DR.
format Online
Article
Text
id pubmed-5703157
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57031572017-11-30 Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy Guha Mazumder, Arpan Chatterjee, Swarnadip Chatterjee, Saunak Gonzalez, Juan Jose Bag, Swarnendu Ghosh, Sambuddha Mukherjee, Anirban Chatterjee, Jyotirmoy Clin Ophthalmol Original Research INTRODUCTION: Image-based early detection for diabetic retinopathy (DR) needs value addition due to lack of well-defined disease-specific quantitative imaging biomarkers (QIBs) for neuroretinal degeneration and spectropathological information at the systemic level. Retinal neurodegeneration is an early event in the pathogenesis of DR. Therefore, development of an integrated assessment method for detecting neuroretinal degeneration using spectropathology and QIBs is necessary for the early diagnosis of DR. METHODS: The present work explored the efficacy of intensity and textural features extracted from optical coherence tomography (OCT) images after selecting a specific subset of features for the precise classification of retinal layers using variants of support vector machine (SVM). Fourier transform infrared (FTIR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy were also performed to confirm the spectropathological attributes of serum for further value addition to the OCT, fundoscopy, and fluorescein angiography (FA) findings. The serum metabolomic findings were also incorporated for characterizing retinal layer thickness alterations and vascular asymmetries. RESULTS: Results suggested that OCT features could differentiate the retinal lesions indicating retinal neurodegeneration with high sensitivity and specificity. OCT, fundoscopy, and FA provided geometrical as well as optical features. NMR revealed elevated levels of ribitol, glycerophosphocholine, and uridine diphosphate N-acetyl glucosamine, while the FTIR of serum samples confirmed the higher expressions of lipids and β-sheet-containing proteins responsible for neoangiogenesis, vascular fragility, vascular asymmetry, and subsequent neuroretinal degeneration in DR. CONCLUSION: Our data indicated that disease-specific spectropathological alterations could be the major phenomena behind the vascular attenuations observed through fundoscopy and FA, as well as the variations in the intensity and textural features observed in OCT images. Finally, we propose a model that uses spectropathology corroborated with specific QIBs for detecting neuroretinal degeneration in early diagnosis of DR. Dove Medical Press 2017-11-22 /pmc/articles/PMC5703157/ /pubmed/29200821 http://dx.doi.org/10.2147/OPTH.S140110 Text en © 2017 Guha Mazumder et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Guha Mazumder, Arpan
Chatterjee, Swarnadip
Chatterjee, Saunak
Gonzalez, Juan Jose
Bag, Swarnendu
Ghosh, Sambuddha
Mukherjee, Anirban
Chatterjee, Jyotirmoy
Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
title Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
title_full Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
title_fullStr Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
title_full_unstemmed Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
title_short Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
title_sort spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703157/
https://www.ncbi.nlm.nih.gov/pubmed/29200821
http://dx.doi.org/10.2147/OPTH.S140110
work_keys_str_mv AT guhamazumderarpan spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy
AT chatterjeeswarnadip spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy
AT chatterjeesaunak spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy
AT gonzalezjuanjose spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy
AT bagswarnendu spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy
AT ghoshsambuddha spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy
AT mukherjeeanirban spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy
AT chatterjeejyotirmoy spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy